Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation

British Journal of Haematology

Volumn 142, Issue 1, 2008, Pages 11-26

  Tichelli, André ^a   Bhatia, Smita ^b   Socié, Gérard ^c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Cardiac; Cardiovascular; Late effects; Stem cell transplantation; Total body irradiation; Toxicity

Indexed keywords

ALEMTUZUMAB; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXORUBICIN; ENALAPRIL; ETOPOSIDE;

AGE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; CONGESTIVE HEART FAILURE; ELECTROCARDIOGRAM; ENDOTHELIUM INJURY; FOLLOW UP; GENDER; GRAFT VERSUS HOST REACTION; HEALTH STATUS; HEART ARRHYTHMIA; HEART DISEASE; HEART EDEMA; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLEEDING; HEART MUSCLE CONDUCTION DISTURBANCE; HEART TAMPONADE; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; INCIDENCE; MORTALITY; MYOCARDITIS; PERICARDITIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

AGE FACTORS; AMYLOIDOSIS; ANTHRACYCLINES; CARDIOVASCULAR DISEASES; GRAFT VS HOST DISEASE; HEART DISEASES; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; RADIOTHERAPY; RISK FACTORS; SURVIVORS;

EID: 44649092773     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07165.x     Document Type: Review

References (129)

1. Ades, L., Guardiola, P. Socie, G. (2002) Second malignancies after allogeneic hematopoietic stem cell transplantation: new insight and current problems. Blood Reviews, 16, 135 146.
2. Aleman, B.M.P., van den Belt-Dusebout, A., De Bruin, M.L., van 't Veer, M.B., Baaijens, M.H.A., de Boer, J.P., Hart, A.A.M., Klokman, W.J., Kuenen, M.A., Ouwens, G.M., Bartelink, H. van Leeuwen, F.E. (2007) Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood, 109, 1878 1886.
3. Alessandrino, P., Bernasconi, P., Caldera, D., Colombo, A., Bonfichi, M., Malcovati, L., Klersy, C., Martinelli, G., Maiocchi, M., Pagnucco, G., Varettoni, M., Perotti, C. Bernasconi, C. (1999) Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplantation, 23, 533 537.
4. Amin, P., Shah, S., Walker, D. Page, S.R. (2001) Adverse metabolic and cardiovascular risk following treatment of acute lymphoblastic leukaemia in childhood; two case reports and a literature review. Diabetic Medicine, 18, 849 853.
5. Angelucci, E., Mariotti, E., Lucarelli, G., Baronciani, D., Cesaroni, P., Durazzi, S.M., Galimberti, M., Giardini, C., Muretto, P., Polchi, P. Sgarbi, E. (1992) Sudden cardiac tamponade after chemotherapy for marrow transplantation in thalassaemia. Lancet, 339, 287 289.
6. Aoudjhane, M., Labopin, M., Gorin, N.C., Shimoni, A., Ruutu, T., Kolb, H.J., Frassoni, F., Boiron, J.M., Yin, J.L., Finke, J., Shouten, H., Blaise, D., Falda, M., Fauser, A.A., Esteve, J., Polge, E., Slavin, S., Niederwieser, D., Nagler, A. Rocha, V. (2005) Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT). Leukemia, 19, 2304 2312.
7. Appelbaum, F., Strauchen, J.A., Graw, Jr., R.G., Savage, D.D., Kent, K.M., Ferrans, V.J. Herzig, G.P. (1976) Acute lethal carditis caused by high-dose combination chemotherapy. A unique clinical and pathological entity. Lancet, 1, 58 62.
8. Armand, P., Kim, H.T., Cutler, C.S., Ho, V.T., Koreth, J., Alyea, E.P., Soiffer, R.J. Antin, J.H. (2007) Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood, 109, 4586 4588.
9. Armand, P., Kim, H.T., Cutler, C.S., Ho, V.T., Koreth, J., Ritz, J., Alyea, E.P., Antin, J.H. Soiffer, R.J. (2008) A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation, 14, 28 35.
10. Auner, H.W., Tinchon, C., Brezinschek, R.I., Eibl, M., Sormann, S., Maizen, C., Linkesch, W., Schmon-Kampel, R., Quehenberger, F., Tiran, A. Sill, H. (2002) Monitoring of cardiac function by serum cardiac troponin T levels, ventricular repolarisation indices, and echocardiography after conditioning with fractionated total body irradiation and high-dose cyclophosphamide. European Journal of Haematology, 69, 1 6.
11. Baccarani, M., Saglio, G., Goldman, J., Hochhaus, A., Simonsson, B., Appelbaum, F., Apperley, J., Cervantes, F., Cortes, J., Deininger, M., Gratwohl, A., Guilhot, F., Horowitz, M., Hughes, T., Kantarjian, H., Larson, R., Niederwieser, D., Silver, R. Hehlmann, R. (2006) Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood, 108, 1809 1820.
12. Baker, K.S., Ness, K.K., Steinberger, J., Carter, A., Francisco, L., Burns, L.J., Sklar, C., Forman, S., Weisdorf, D.J., Gurney, J.G. Bhatia, S. (2007) Diabetes, hypertension and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Blood, 115, 1765 1772.
13. Basavaraju, S.R. Easterly, C.E. (2002) Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications. Medical Physics, 29, 2391 2403.
14. Bhatia, S., Robison, L.L., Francisco, L., Carter, A., Liu, Y., Grant, M., Baker, K.S., Fung, H., Gurney, J.G., McGlave, P.B., Nademanee, A., Ramsay, N.K., Stein, A., Weisdorf, D.J. Forman, S.J. (2005) Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood, 105, 4215 4222.
15. Bhatia, S., Francisco, L., Carter, A., Sun, C.L., Baker, K.S., Gurney, J.G., McGlave, P.B., Nademanee, A., O'Donnell, M., Ramsay, N.K., Robison, L.L., Snyder, D., Stein, A., Forman, S.J. Weisdorf, D.J. (2007) Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood, 110, 3784 3792.
16. Biedermann, B.C., Sahner, S., Gregor, M., Tsakiris, D.A., Jeanneret, C., Pober, J.S. Gratwohl, A. (2002) Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet, 359, 2078 2083.
17. Binks, M., Passweg, J.R., Furst, D., McSweeney, P., Sullivan, K., Besenthal, C., Finke, J., Peter, H.H., van Laar, J., Breedveld, F.C., Fibbe, W.E., Farge, D., Gluckman, E., Locatelli, F., Martini, A., van den Hoogen, F., van de Putte, L., Schattenberg, A.V.N., Arnold, R., Bacon, P.A., Emery, P., Espigado, I., Hertenstein, B., Hiepe, F., Kashyap, A., Kotter, I., Marmont, A., Martinez, A., Pascual, M.J., Gratwohl, A., Prentice, H.G., Black, C. Tyndall, A. (2001) Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Annals of the Rheumatic Diseases, 60, 577 584.
18. Boivin, J.F., Hutchison, G.B., Lubin, J.H. Mauch, P. (1992) Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer, 69, 1241 1247.
19. Braverman, A.C., Antin, J.H., Plappert, M.T., Cook, E.F. Lee, R.T. (1991) Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. Journal of Clinical Oncology, 9, 1215 1223.
20. Broers, A.E., van der, H.B., Haze, S., Braakman, E., Gratama, J.W., Lowenberg, B. Cornelissen, J.J. (2005) A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation. Experimental Hematology, 33, 912 919.
21. Calmels, B., Lemarie, C., Esterni, B., Malugani, C., Charbonnier, A., Coso, D., de Colella, J.M., Deconinck, E., Caillot, D., Viret, F., Ladaique, P., Lapierre, V. Chabannon, C. (2007) Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product. Transfusion, 47, 1268 1275.
22. Carver, J.R., Shapiro, C.L., Ng, A., Jacobs, L., Schwartz, C., Virgo, K.S., Hagerty, K.L., Somerfield, M.R. Vaughn, D.J. (2007) American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. Journal of Clinical Oncology, 25, 3991 4008.
23. Chan, K.W., Taylor, G.P., Shepherd, J.D. Shepherd, W.E. (1989) Coronary artery disease following bone marrow transplantation. Bone Marrow Transplantation, 4, 327 330.
24. Chen-Plotkin, A.S., Vossel, K.A., Samuels, M.A. Chen, M.H. (2007) Encephalopathy, stroke, and myocardial infarction with DMSO use in stem cell transplantation. Neurology, 68, 859 861.
25. Chow, L.Q., Bahlis, N., Russell, J., Chaudhry, A., Morris, D., Brown, C. Stewart, D.A. (2005) Autologous transplantation for primary systemic AL amyloidosis is feasible outside a major amyloidosis referral centre: the Calgary BMT Program experience. Bone Marrow Transplantation, 36, 591 596.
26. Coghlan, J.G., Handler, C.E. Kottaridis, P.D. (2007) Cardiac assessment of patients for haematopoietic stem cell transplantation. Best Practice & Research. Clinical Haematology, 20, 247 263.
27. Constine, L.S., Wolkov, H.B., Yahalom, J., Mauch, P.M., Deming, R.L., Dosoretz, D.E., Elman, A.J., Hoppe, R.T., Pistenmaa, D.A., Prosnitz, L.R., Chauvenet, A., Connors, J.M., Glick, J.H. Leibel, S. (2000) Pediatric Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria. Radiology, 215 (Suppl. 1225 1256.
28. Cordoba, R., Arrieta, R., Kerguelen, A. Hernandez-Navarro, F. (2007) The occurrence of adverse events during the infusion of autologous peripheral blood stem cells is related to the number of granulocytes in the leukapheresis product. Bone Marrow Transplantation, 40, 1063 1067.
29. Couriel, D.R., Saliba, R., Escalon, M.P., Hsu, Y., Ghosh, S., Ippoliti, C., Hicks, K., Donato, M., Giralt, S., Khouri, I.F., Hosing, C., Lima, M.J., Andersson, B., Neumann, J. Champlin, R. (2005) Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. British Journal of Haematology, 130, 409 417.
30. Dorresteijn, L.D.A., Kappelle, A.C., Boogerd, W., Klokman, W.J., Balm, A.J.M., Keus, R.B., van Leeuwen, F.E. Bartelink, H. (2002) Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. Journal of Clinical Oncology, 20, 282 288.
31. Elkind, M.S. (2006) Inflammation, atherosclerosis, and stroke. Neurologist, 12, 140 148.
32. Ferry, C. Socie, G. (2003) Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned? Experimental Hematology, 31, 1182 1186.
33. Ferry, C., Gemayel, G., Rocha, V., Labopin, M., Esperou, H., Robin, M., de Latour, R.P., Ribaud, P., Devergie, A., Leblanc, T., Gluckman, E., Baruchel, A. Socie, G. (2007) Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies. Bone Marrow Transplantation, 40, 219 224.
34. Friedlander, A.H., Sung, E.C. Child, J.S. (2003) Radiation-induced heart disease after Hodgkin's disease and breast cancer treatment: dental implications. The Journal of the American Dental Association, 134, 1615 1620.
35. Gatt, M.E., Liebster, D., Leibowitz, D. Matzner, Y. (2003) Acute myocardial infarction after bone marrow transplantation: an unsuspected late complication. Annals of Hematology, 82, 136 138.
36. Gattermann, N., Porter, J., Lopez, L.F. Seymour, J. (2005) Consensus statement on iron overload in myelodysplastic syndromes in: iron overload in myelodysplastic syndromes. Hematology/oncology Clinics of North America, 19, 18 26.
37. Ghobrial, I.M., Bunch, T.J., Caplice, N.M., Edwards, W.D., Miller, D.V. Litzow, M.R. (2004) Fatal coronary artery disease after unrelated donor bone marrow transplantation. Mayo Clinic Proceedings, 79, 403 406.
38. Gilman, A.L., Kooy, N.W., Atkins, D.L., Ballas, Z., Rumelhart, S., Holida, M., Lee, N. Goldman, F. (1998) Complete heart block in association with graft-versus-host disease. Bone Marrow Transplantation, 21, 85 88.
39. Goldberg, M.A., Antin, J.H., Guinan, E.C. Rappeport, J.M. (1986) Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood, 68, 1114 1118.
40. Gottdiener, J.S., Appelbaum, F.R., Ferrans, V.J., Deisseroth, A. Ziegler, J. (1981) Cardiotoxicity associated with high-dose cyclophosphamide therapy. Archives of Internal Medicine, 141, 758 763.
41. Gratwohl, A., Hermans, J., Goldman, J.M., Arcese, W., Carreras, E., Devergie, A., Frassoni, F., Gahrton, G., Kolb, H.J., Niederwieser, D., Ruutu, T., Vernant, J.P., de, W.T. Apperley, J. (1998) Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet, 352, 1087 1092.
42. Green, D.M., Hyland, A., Chung, C.S., Zevon, M.A. Hall, B.C. (1999) Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescence. Journal of Clinical Oncology, 17, 3207 3215.
43. Hampton, J.R., Cowley, A.J. Wnuk-Wojnar, A.M. (1998) Failure of an ACE inhibitor to improve exercise tolerance. A randomized study of trandolapril. Trandolapril study group. European Heart Journal, 19, 1823 1828.
44. Hancock, S.L., Tucker, M.A. Hoppe, R.T. (1993) Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA, 270, 1949 1955.
45. Hansson, G.K. (2005) Inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine, 352, 1685 1695.
46. Heidenreich, P.A., Hancock, S.L., Lee, B.K., Mariscal, C.S. Schnittger, I. (2003) Asymptomatic cardiac disease following mediastinal irradiation. Journal of the American College of Cardiology, 42, 743 749.
47. Hequet, O., Le, Q.H., Moullet, I., Pauli, E., Salles, G., Espinouse, D., Dumontet, C., Thieblemont, C., Arnaud, P., Antal, D., Bouafia, F. Coiffier, B. (2004) Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults. Journal of Clinical Oncology, 22, 1864 1871.
48. Hidalgo, J.D., Krone, R., Rich, M.W., Blum, K., Adkins, D., Fan, M.Y., Brown, R., Devine, S., Graubert, T., Blum, W., Tomasson, M., Goodnough, L.T., Vij, R., DiPersio, J. Khoury, H. (2004) Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Bone Marrow Transplantation, 34, 615 619.
49. Hogarty, A.N., Leahey, A., Zhao, H., Hogarty, M.D., Bunin, N., Cnaan, A. Paridon, S.M. (2000) Longitudinal evaluation of cardiopulmonary performance during exercise after bone marrow transplantation in children. The Journal of Pediatrics, 136, 311 317.
50. Hull, M.C., Morris, C.G., Pepine, C.J. Mendenhall, N.P. (2003) Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. JAMA, 290, 2831 2837.
51. Jabbour, E., Kantarjian, H.M., Koller, C. Taher, A. (2008) Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes. Cancer, 112, 1089 1095.
52. Jaccard, A., Moreau, P., Leblond, V., Leleu, X., Benboubker, L., Hermine, O., Recher, C., Asli, B., Lioure, B., Royer, B., Jardin, F., Bridoux, F., Grosbois, B., Jaubert, J., Piette, J.C., Ronco, P., Quet, F., Cogne, M., Fermand, J.P., the Myelome Autogreffe (MAG) and Intergroupe Francophone du Myelome (IFM) Intergroup (2007) High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. The New England Journal of Medicine, 357, 1083 1093.
53. Jensen, B.V., Nielsen, S.L. Skovsgaard, T. (1996) Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy. Lancet, 347, 297 299.
54. Jong, P., Yusuf, S., Rousseau, M.F., Ahn, S.A. Bangdiwala, S.I. (2003) Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study. Lancet, 361, 1843 1848.
55. Kilickap, S., Barista, I., Akgul, E., Aytemir, K., Aksoyek, S., Aksoy, S., Celik, I., Kes, S. Tekuzman, G. (2005) cTnT can be a useful marker for early detection of anthracycline cardiotoxicity. Annals of Oncology, 16, 798 804.
56. Kolb, H.J., Socie, G., Duell, T., Van Lint, M.T., Tichelli, A., Apperley, J.F., Nekolla, E., Ljungman, P., Jacobsen, N., van Weel, M., Wick, R., Weiss, M. Prentice, H.G. (1999) Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Annals of Internal Medicine, 131, 738 744.
57. Kumar, S., Dispenzieri, A., Gertz, M.A., Mehta, J., Lachmann, H.J., Wechalekar, A.D., Gillmore, J.D., Lokhorst, H.M., Hazenberg, B.P.C., Croockewit, A., Comenzo, R.L., Steingart, R.M., Cohen, A.D., Jaccard, A., Moreau, P. Fermand, J.P. (2008) High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. The New England Journal of Medicine, 358, 91 93.
58. Kupari, M., Volin, L., Suokas, A., Timonen, T., Hekali, P. Ruutu, T. (1990) Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings. Bone Marrow Transplantation, 5, 91 98.
59. Kuruvilla, J., Forrest, D.L., Lavoie, J.C., Nantel, S.H., Shepherd, J.D., Song, K.W., Sutherland, H.J., Toze, C.L., Hogge, D.E. Nevill, T.J. (2004) Characteristics and outcome of patients developing endocarditis following hematopoietic stem cell transplantation. Bone Marrow Transplantation, 34, 969 973.
60. Landier, W., Bhatia, S., Eshelman, D.A., Forte, K.J., Sweeney, T., Hester, A.L., Darling, J., Armstrong, F.D., Blatt, J., Constine, L.S., Freeman, C.R., Friedman, D.L., Green, D.M., Marina, N., Meadows, A.T., Neglia, J.P., Oeffinger, K.C., Robison, L.L., Ruccione, K.S., Sklar, C.A. Hudson, M.M. (2004) Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. Journal of Clinical Oncology, 22, 4979 4990.
61. Lee, C.K., Aeppli, D. Nierengarten, M.E. (2000) The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience. International Journal of Radiation Oncology, Biology, Physics, 48, 169 179.
62. Legault, L. Bonny, Y. (1999) Endocrine complications of bone marrow transplantation in children. Pediatric Transplantation, 3, 60 66.
63. Leung, W., Ahn, H., Rose, S.R., Phipps, S., Smith, T., Gan, K., O'Connor, M., Hale, G.A., Kasow, K.A., Barfield, R.C., Madden, R.M. Pui, C.H. (2007) A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation. Medicine (Baltimore), 86, 215 224.
64. Link, K., Moell, C., Garwicz, S., Cavallin-Stahl, E., Bjork, J., Thilen, U., Ahren, B. Erfurth, E.M. (2004) Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. Journal of Clinical Endocrinology Metabolism, 89, 5003 5012.
65. Lipshultz, S.E. Colan, S.D. (2004) Cardiovascular trials in long-term survivors of childhood cancer. Journal of Clinical Oncology, 22, 769 773.
66. Lipshultz, S.E., Lipsitz, S.R., Sallan, S.E., Simbre, V.C., Shaikh, S.L., Mone, S.M., Gelber, R.D. Colan, S.D. (2002) Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. Journal of Clinical Oncology, 20, 4517 4522.
67. Lloyd-Jones, D.M., Leip, E.P., Larson, M.G., D'Agostino, R.B., Beiser, A., Wilson, P.W., Wolf, P.A. Levy, D. (2006) Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation, 113, 791 798.
68. Lucarelli, G. Gaziev, J. (2008) Advances in the allogeneic transplantation for thalassemia. Blood Reviews, 22, 53 63.
69. Lucarelli, G., Galimberti, M., Polchi, P., Angelucci, E., Baronciani, D., Giardini, C., Politi, P., Durazzi, S.M., Muretto, P. Albertini, F. (1990) Bone marrow transplantation in patients with thalassemia. The New England Journal of Medicine, 322, 417 421.
70. Lucarelli, G., Angelucci, E., Giardini, C., Baronciani, D., Galimberti, M., Polchi, P., Bartolucci, M., Muretto, P. Albertini, F. (1993) Fate of iron stores in thalassaemia after bone-marrow transplantation. Lancet, 342, 1388 1391.
71. Lucarelli, G., Clift, R.A., Galimberti, M., Polchi, P., Angelucci, E., Baronciani, D., Giardini, C., Andreani, M., Manna, M., Nesci, S., Agostinelli, F., Rapa, S., Ripalti, M. Albertini, F. (1996) Marrow transplantation for patients with thalassemia: results in class 3 patients. Blood, 87, 2082 2088.
72. Maggioni, A.P. Latini, R. (2002) The angiotensin-receptor blockers: from antihypertensives to cardiovascular all-round medications in 10 years? Blood Pressure, 11, 328 338.
73. Mariotti, E., Angelucci, E., Agostini, A., Baronciani, D., Sgarbi, E. Lucarelli, G. (1998) Evaluation of cardiac status in iron-loaded thalassaemia patients following bone marrow transplantation: improvement in cardiac function during reduction in body iron burden. British Journal of Haematology, 103, 916 921.
74. Maris, M.B., Sandmaier, B.M., Storer, B.E., Chauncey, T., Stuart, M.J., Maziarz, R.T., Agura, E., Langston, A.A., Pulsipher, M., Storb, R. Maloney, D.G. (2004) Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma. Blood, 104, 3535 3542.
75. Masuko, M., Ito, M., Kurasaki, T., Yano, T., Takizawa, J., Toba, K., Aoki, S., Fuse, I., Kodama, M., Furukawa, T. Aizawa, Y. (2007) Plasma brain natriuretic peptide during myeloablative stem cell transplantation. Internal Medicine, 46, 551 555.
76. Mertens, A.C., Yasui, Y., Neglia, J.P., Potter, J.D., Nesbit, Jr., M.E., Ruccione, K., Smithson, W.A. Robison, L.L. (2001) Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. Journal of Clinical Oncology, 19, 3163 3172.
77. Milone, G., Mercurio, S., Strano, A., Leotta, S., Pinto, V., Battiato, K., Coppoletta, S., Murgano, P., Farsaci, B., Privitera, A. Giustolisi, R. (2007) Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age. Cytotherapy, 9, 348 355.
78. Moser, E.C., Noordijk, E.M., Carde, P., Tirelli, U., Baars, J.W., Thomas, J., Bron, D., Meerwaldt, J.H., van, G.M., Raemaekers, J.M. Kluin-Nelemans, H.C. (2005) Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials. Clinical Lymphoma & Myeloma, 6, 122 130.
79. Murata, H., Janin, A., Leboeuf, C., Soulier, J., Gluckman, E., Meignin, V. Socie, G. (2007) Donor-derived cells and human graft-versus-host disease of the skin. Blood, 109, 2663 2665.
80. Murdych, T. Weisdorf, D.J. (2001) Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997. Bone Marrow Transplantation, 28, 283 287.
81. Muretto, P., Angelucci, E. Lucarelli, G. (2002) Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation. Annals of Internal Medicine, 136, 667 672.
82. Oshima, K., Sakata-Yanagimoto, M., sano-Mori, Y., Izutsu, K., Watanabe, T., Shoda, E., Ogawa, S., Motokura, T., Chiba, S., Kurokawa, M., Hirai, H. Kanda, Y. (2005) Cardiac complications after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab. Bone Marrow Transplantation, 36, 821 824.
83. Palladini, G., Campana, C., Klersy, C., Balduini, A., Vadacca, G., Perfetti, V., Perlini, S., Obici, L., Ascari, E., d'Eril, G.M., Moratti, R. Merlini, G. (2003) Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation, 107, 2440 2445.
84. Pene, F., Aubron, C., Azoulay, E., Blot, F., Thiery, G., Raynard, B., Schlemmer, B., Nitenberg, G., Buzyn, A., Arnaud, P., Socie, G. Mira, J.P. (2006) Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. Journal of Clinical Oncology, 24, 643 649.
85. Pfeffer, M.A., Swedberg, K., Granger, C.B., Held, P., McMurray, J.J., Michelson, E.L., Olofsson, B., Ostergren, J., Yusuf, S. Pocock, S. (2003) Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet, 362, 759 766.
86. Platzbecker, U., Klingel, K., Thiede, C., Freiberg-Richter, J., Schuh, D., Ehninger, G., Kandolf, R. Bornhauser, M. (2001) Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin. Bone Marrow Transplantation, 27, 107 109.
87. Prevost, D., Taylor, G., Sanatani, S. Schultz, K.R. (2004) Coronary vessel involvement by chronic graft-versus-host disease presenting as sudden cardiac death. Bone Marrow Transplantation, 34, 655 656.
88. Rackley, C., Schultz, K.R., Goldman, F.D., Chan, K.W., Serrano, A., Hulse, J.E. Gilman, A.L. (2005) Cardiac manifestations of graft-versus-host disease. Biology of Blood and Marrow Transplantation, 11, 773 780.
89. Reinders, J.G., Heijmen, B.J., Olofsen-van Acht, M.J., van Putten, W.L. Levendag, P.C. (1999) Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. Radiotherapy and Oncology, 51, 35 42.
90. Rhodes, M., Lautz, T., Kavanaugh-Mchugh, A., Manes, B., Calder, C., Koyama, T., Liske, M., Parra, D. Frangoul, H. (2005) Pericardial effusion and cardiac tamponade in pediatric stem cell transplant recipients. Bone Marrow Transplantation, 36, 139 144.
91. Rizzo, J.D., Wingard, J.R., Tichelli, A., Lee, S.J., Van Lint, M.T., Burns, L.J., Davies, S.M., Ferrara, J.L. Socie, G. (2006a) Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT). Bone Marrow Transplantation, 37, 249 261.
92. Rizzo, J.D., Wingard, J.R., Tichelli, A., Lee, S.J., Van Lint, M.T., Burns, L.J., Davies, S.M., Ferrara, J.L. Socie, G. (2006b) Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 12, 138 151.
93. Rosen, O., Massenkeil, G., Hiepe, F., Pest, S., Hauptmann, S., Radtke, H., Burmester, G., Thiel, A., Radbruch, A., Heymer, B. Arnold, R. (2001) Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy. Bone Marrow Transplantation, 27, 657 658.
94. Ruiz-Soto, R., Sergent, G., Gisselbrecht, C., Larghero, J., Ertault, M., Hennequin, C., Manson, J., de, K.E., Briere, J. Mounier, N. (2005) Estimating late adverse events using competing risks after autologous stem-cell transplantation in aggressive non-Hodgkin lymphoma patients. Cancer, 104, 2735 2742.
95. Saba, N., Sutton, D., Ross, H., Siu, S., Crump, R., Keating, A. Stewart, A. (1999) High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant. Bone Marrow Transplantation, 24, 853 855.
96. Saccardi, R., Tyndall, A., Coghlan, G., Denton, C., Edan, G., Emdin, M., Farge, D., Fassas, A., Finke, J., Furst, D., Lassus, M., Mancardi, G., Miniati, I., Mini, E., Pagliai, F., Passweg, J., Pignone, A., van Laar, J.M., Bocelli-Tyndall, C. Matucci-Cerinic, M. (2004) Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis. Bone Marrow Transplantation, 34, 877 881.
97. Salooja, N., Szydlo, R.M., Socie, G., Rio, B., Chatterjee, R., Ljungman, P., Van Lint, M.T., Powles, R., Jackson, G., Hinterberger-Fischer, M., Kolb, H.J. Apperley, J.F. (2001) Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet, 358, 271 276.
98. Sanchorawala, V., Wright, D.G., Seldin, D.C., Dember, L.M., Finn, K., Falk, R.H., Berk, J., Quillen, K. Skinner, M. (2001) An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplantation, 28, 637 642.
99. Schmitz, N., Bacigalupo, A., Hasenclever, D., Nagler, A., Gluckman, E., Clark, P., Bourquelot, P., Greinix, H., Frickhofen, N., Ringden, O., Zander, A., Apperley, J.F., Gorin, C., Borkett, K., Schwab, G., Goebel, M., Russell, N.H. Gratwohl, A. (1998) Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation, 21, 995 1003.
100. Schultz-Hector, S. (1992) Radiation-induced heart disease: review of experimental data on dose response and pathogenesis. International Journal of Radiation Biology, 61, 149 160.
101. Seber, A., Khan, S.P. Kersey, J.H. (1996) Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease. Bone Marrow Transplantation, 17, 207 211.
102. Silber, J.H., Cnaan, A., Clark, B.J., Paridon, S.M., Chin, A.J., Rychik, J., Hogarty, A.N., Cohen, M.I., Barber, G., Rutkowski, M., Kimball, T.R., DeLaat, C., Steinherz, L.J. Zhao, H. (2004) Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. Journal of Clinical Oncology, 22, 820 828.
103. Skinner, M., Sanchorawala, V., Seldin, D.C., Dember, L.M., Falk, R.H., Berk, J.L., Anderson, J.J., O'Hara, C., Finn, K.T., Libbey, C.A., Wiesman, J., Quillen, K., Swan, N. Wright, D.G. (2004) High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Annals of Internal Medicine, 140, 85 93.
104. Snowden, J.A., Hill, G.R., Hunt, P., Carnoutsos, S., Spearing, R.L., Espiner, E. Hart, D.N. (2000) Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide. Bone Marrow Transplantation, 26, 309 313.
105. Socie, G., Salooja, N., Cohen, A., Rovelli, A., Carreras, E., Locasciulli, A., Korthof, E., Weis, J., Levy, V. Tichelli, A. (2003) Nonmalignant late effects after allogeneic stem cell transplantation. Blood, 101, 3373 3385.
106. Sorror, M.L., Maris, M.B., Storb, R., Baron, F., Sandmaier, B.M., Maloney, D.G. Storer, B. (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood, 106, 2912 2919.
107. Sorror, M.L., Sandmaier, B.M., Storer, B.E., Maris, M.B., Baron, F., Maloney, D.G., Scott, B.L., Deeg, H.J., Appelbaum, F.R. Storb, R. (2007) Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation. Journal of Clinical Oncology, 25, 4246 4254.
108. Soubani, A.O., Miller, K.B. Hassoun, P.M. (1996) Pulmonary complications of bone marrow transplantation. Chest, 109, 1066 1077.
109. Stoll, G. Bendszus, M. (2006) Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke, 37, 1923 1932.
110. Talvensaari, K.K., Lanning, M., Tapanainen, P. Knip, M. (1996) Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. Journal of Clinical Endocrinology and Metabolism, 81, 3051 3055.
111. Taskinen, M., Saarinen-Pihkala, U.M., Hovi, L. Lipsanen-Nyman, M. (2000) Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. The Lancet, 356, 993 997.
112. Taskinen, M., Lipsanen-Nyman, M., Tiitinen, A., Hovi, L. Saarinen-Pihkala, U.M. (2007) Insufficient growth hormone secretion is associated with metabolic syndrome after allogeneic stem cell transplantation in childhood. Journal of Pediatric Hematology/oncology, 29, 529 534.
113. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. The New England Journal of Medicine, 325, 293 302.
114. The SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. The New England Journal of Medicine, 327, 685 691.
115. Tichelli, A. Socie, G. (2005) Considerations for Adult Cancer Survivors. American Society of Hematology Education Program Book, 516 522.
116. Tichelli, A., Gratwohl, A., Egger, T., Roth, J., Prunte, A., Nissen, C. Speck, B. (1993) Cataract formation after bone marrow transplantation. Annals of Internal Medicine, 119, 1175 1180.
117. Tichelli, A., Bucher, C., Rovo, A., Stussi, G., Stern, M., Paulussen, M., Halter, J., Meyer-Monard, S., Heim, D., Tsakiris, D.A., Biedermann, B., Passweg, J.R. Gratwohl, A. (2007) Premature cardiovascular disease after allogeneic stem cell transplantation. Blood, 110, 3463 3471.
118. Toren, A. Nagler, A. (1997) Massive pericardial effusion complicating the course of chronic graft-versus-host disease (cGVHD) in a child with acute lymphoblastic leukemia following allogeneic bone marrow transplantation. Bone Marrow Transplantation, 20, 805 807.
119. Tyndall, A., Fassas, A., Passweg, J., Ruiz de, E.C., Attal, M., Brooks, P., Black, C., Durez, P., Finke, J., Forman, S., Fouillard, L., Furst, D., Holmes, J., Joske, D., Jouet, J., Kotter, I., Locatelli, F., Prentice, H., Marmont, A.M., McSweeney, P., Musso, M., Peter, H.H., Snowden, J.A., Sullivan, K., Gratwohl, A., for the Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation (EBMT) the European League Against Rheumatism (EULAR) and on behalf of the International Stem Cell Project for Autoimmune Disease. (1999) Autologous haematopoietic stem cell transplants for autoimmune disease - feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease. Bone Marrow Transplantation, 24, 729 734.
120. Tyndall, A., Passweg, J. Gratwohl, A. (2001) Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000. Annals of the Rheumatic Diseases, 60, 702 707.
121. Uderzo, C., Pillon, M., Corti, P., Tridello, G., Tana, F., Zintl, F., Nysom, K., Galambrun, C., Fagioli, F., Varotto, S., Messina, C., Verdeguer, A., Urban, C., Faraci, M., Dini, G., Fedeli, S., Tichelli, A., Rovelli, A. Socie, G. (2007) Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Bone Marrow Transplantation, 39, 667 675.
122. Ueda, T., Manabe, A., Kikuchi, A., Yoshino, H., Ebihara, Y., Ishii, T., Yagasaki, H., Mitsui, T., Hisakawa, H., Masunaga, A., Tsuji, K. Nakahata, T. (2000) Massive pericardial and pleural effusion with anasarca following allogeneic bone marrow transplantation. International Journal of Hematology, 71, 394 397.
123. Valagussa, P., Zambetti, M., Biasi, S., Moliterni, A., Zucali, R. Bonadonna, G. (1994) Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancer. Annals of Oncology, 5, 209 216.
124. Weisser, M., Schleuning, M., Ledderose, G., Rolf, B., Schnittger, S., Schoch, C., Schwerdtfeger, R. Kolb, H.J. (2004) Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease. Bone Marrow Transplantation, 34, 1083 1088.
125. Windrum, P., Morris, T.C., Drake, M.B., Niederwieser, D. Ruutu, T. (2005) Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplantation, 36, 601 603.
126. Wouters, K.A., Kremer, L.C.M., Miller, T.L., Herman, E.H. Lipshultz, S.E. (2005) Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies. British Journal of Haematology, 131, 561 578.
127. Yeh, E.T., Tong, A.T., Lenihan, D.J., Yusuf, S.W., Swafford, J., Champion, C., Durand, J.B., Gibbs, H., Zafarmand, A.A. Ewer, M.S. (2004) Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation, 109, 3122 3131.
128. Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R. Dagenais, G. (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. The New England Journal of Medicine, 342, 145 153.
129. Zenhausern, R., Tobler, A., Leoncini, L., Hess, O.M. Ferrari, P. (2000) Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Annals of Hematology, 79, 523 526.